Nosocomial pneumonia
Nosocomial pneumonia is generally defined as a new pulmonary infiltrate on chest radiography, combined with evidence of infection expressed as fever, purulent respiratory secretions and/or leucocytosis, with onset at least 72 h after admission. It is the most frequent lethal nosocomial infection (overall mortality 8 to 20%).
Aetiology—most cases are caused by Gram-negative bacteria (50–70%) or Staphylococcus aureus (20–30%). Gram-negative bacteria reach the lung by aspiration of gastric contents or by microaspiration of upper airway secretions, throat cultures revealing that 60 to 70% of patients on intensive care units are colonized by these organisms (compared to 2–3% of healthy people).
Prevention—the best proven methods of prevention are by nursing the patient in the semi-upright position to reduce the risk of aspiration, and hand washing between patients to prevent transmission of nosocomial pathogens.
Diagnosis—this is often straightforward: due to easy access to cultures from tracheal aspirates and the ease of growing likely pathogens.
Management—when empirical decisions are necessary in seriously ill patients, the favoured drugs directed against Gram-negative bacteria are ceftazidime, cefepime, imipenem/meropenem, doripenem, piperacillin/piperacillin–tazobactam, ticarcillin/ticarcillin–sulbactam, or ciprofloxacin. For S. aureus, vancomycin or linezolid is added.
Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.